Celularity Inc. Class A Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CELU, updated each market day.
CELU AI Sentiment
AI sees no strong directional signal for Celularity Inc. Class A Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Celularity Inc. Class A Common Stock
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
Sector
Exchange
Market Cap
$39,219,390
Cap Tier
Employees
123
Headquarters
FLORHAM PARK, NJ
Listed Since
July 19, 2021
Website
CELU Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CELU Volatility
Celularity Inc. Class A Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
